Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OM-89 in Recurrent Chronic Prostatitis/CPPS
NCT06345014Phase 4Recruiting
- Sponsor
- AJU PHARM Co., Ltd.
- Start
- Dec 2023
- Primary completion
- Dec 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of OM-89 in chronic prostatitis (CP), chronic pelvic pain syndrome (CPPS), sponsored by AJU PHARM Co., Ltd.. Started Dec 2023; status: recruiting.
02
Drugs
OM-89
03
Conditions
chronic prostatitis (CP)chronic pelvic pain syndrome (CPPS)
Beyond the preview
Go deeper on NCT06345014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06345014.